Australian ambassador visits CSL Behring
CSL Behring management welcomes Australian Ambassador to Germany Philip Green.
New R&D Campus in Marburg
Video: “Topping-out” milestone celebrated in Marburg for facility scheduled to open in 2022.
From immune system problems to bleeding disorders and more – plasma-based therapies treat many health conditions.
Hemophilia B gene therapy
CSL closes commercialization and license agreement for Hemophilia B gene therapy.
A Network for the Orphans of Medicine
The future of rare disease diagnostics in the focus of science and industry
Donation for “Menschenskinder Marburg e.V.”
Last year’s “Cents for a good cause” will benefit children and young people with mental illnesses.
Leading an active, fulfilling life
People with a rare disease are often well aware of just how difficult and frustrating it can be to get the right diagnosis and appropriate treatment for their condition. This can sometimes take several years. But once found, many patients are finally able to live active and fulfilling lives. Read Karen Skålvoll’s story, one of our alpha-1 antitrypsin deficiency patients, and learn more about the condition.
Patient with Alpha-1 Antitrypsin Deficiency
Karen doesn’t let alpha-1 antitrypsin deficiency limit her active and fulfilling life. She even sets world records!